CSIMarket
 


Respirerx Pharmaceuticals Inc   (RSPI)
Other Ticker:  
 

Respirerx Pharmaceuticals Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Respirerx Pharmaceuticals Inc in the second quarter 2023?
Due to the lack of equity, it was not possible to calculate Respirerx Pharmaceuticals Inc 's return on equity (ROE) in its second quarter 2023

What is ROE?



Return On Equity (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -3 -4 -4 -4 -3
Return On Equity (TTM) - - - - -
RSPI's Total Ranking # # # # #
Equity (TTM) in Millions -12 -12 -12 -12 -11
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





RSPI Annual Return On Equity (Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
Total Equity in Millions -12 -10 -8 -7 -6
Y / Y Equity Change - - - - -
Net Income in Millions -4 -3 -4 -2 -3
Y / Y Net Income Change - - - - -
Return On Equity - - - - -





More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
RSPI's' Return on Equity at Yahoo Finance
RSPI's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for RSPI's Competitors
Return On Equity for Respirerx Pharmaceuticals Inc 's Suppliers
Roe for RSPI's Customers




Companies with similar Return On Equity at Jun 30 2023, within Healthcare Sector ROE
Davita Inc   74.49 %
Medpace Holdings Inc   72.88 %
Chimerix Inc   72.53 %
Dariohealth Corp   71.65 %
Voyager Therapeutics Inc   69.09 %
Science 37 Holdings Inc   65.27 %
Vaso Corporation  61.62 %
Eli Lilly And Company  59.90 %
Kiniksa Pharmaceuticals ltd   58.48 %
Abbvie inc   58.42 %
Star Equity Holdings Inc   54.61 %
Ocuphire Pharma Inc   54.45 %
Entera Bio Ltd   48.66 %
Zoetis Inc   48.61 %
Harmony Biosciences Holdings inc   47.82 %
Shockwave Medical Inc   47.48 %
Zymeworks Inc   46.66 %
Enzo Biochem Inc  46.32 %
Assertio Holdings inc   45.16 %
Cv Sciences Inc   45.08 %
Tenet Healthcare Corp  44.05 %
Fusion Pharmaceuticals Inc   41.18 %
Synaptogenix Inc   40.31 %
National Research Corporation  39.94 %
Orgenesis Inc   37.77 %
Revelation Biosciences Inc   37.76 %
Catalyst Pharmaceuticals Inc   36.13 %
Singular Genomics Systems Inc   35.20 %
Exicure Inc   34.49 %
Hologic Inc  32.61 %


Date modified: 2023-08-25T21:47:42+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com